Ustekinumab (Stelara)

ustekinumab · Janssen Biotech, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Ustekinumab (Stelara), covering 2024-03-18 to 2026-03-02. Get the full timeline:

Most recent: Clinical Trial Update: Guselkumab Vs Ustekinumab in Stricturing Crohn's Disease